Nitrocefin

For research use only. Not for therapeutic Use.

  • CAT Number: R039865
  • CAS Number: 41906-86-9
  • Molecular Formula: C21H16N4O8S2
  • Molecular Weight: 516.49
  • Purity: ≥95%
Inquiry Now

Nitrocefin(Cat No.:R039865)is a high-purity chromogenic cephalosporin substrate widely used in microbiological and biochemical research. It is specifically designed to detect β-lactamase activity by undergoing a color change from yellow to red upon hydrolysis. This property makes Nitrocefin an essential tool for identifying β-lactamase-producing bacteria and assessing the efficacy of β-lactamase inhibitors. Its high sensitivity and specificity enable rapid screening in clinical diagnostics and antibiotic resistance studies. Nitrocefin is crucial for advancing research on bacterial resistance mechanisms and optimizing antimicrobial therapies.


Catalog Number R039865
CAS Number 41906-86-9
Synonyms

(6R,7R)-3-[(1E)-2-(2,4-dinitrophenyl)ethenyl]-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; [6R-[3(E),6α,7β]]-3-[2-(2,4-dinitrophenyl)ethenyl]-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-

Molecular Formula C21H16N4O8S2
Purity ≥95%
Target Beta-lactamase
Storage -20°C
IUPAC Name (6R,7R)-3-[(E)-2-(2,4-dinitrophenyl)ethenyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
InChI InChI=1S/C21H16N4O8S2/c26-16(9-14-2-1-7-34-14)22-17-19(27)23-18(21(28)29)12(10-35-20(17)23)4-3-11-5-6-13(24(30)31)8-15(11)25(32)33/h1-8,17,20H,9-10H2,(H,22,26)(H,28,29)/b4-3+/t17-,20-/m1/s1
InChIKey LHNIIDJCEODSHA-OQRUQETBSA-N
SMILES C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CS3)C(=O)O)/C=C/C4=C(C=C(C=C4)[N+](=O)[O-])[N+](=O)[O-]
Reference

<p>O/’Callaghan, Cynthia H. et. al. /Novel Method for Detection of B-Lactamases by Using a Chromogenic Cephalosporin Substrate./ <em>Antimicrobial Agents and Chemotherapy</em> 1.4 (1972): 283-88. <em>Ncbi.gov</em> Web. 10 Oct. 2012.</p><p>Parr, T. R., Jr. /Simple Screening Method for Beta-lactamase-positive and -negative Ampicillin-resistant Haemophilus Influenzae Isolates./ <em>Journal of Clinical Microbiology</em> 20.1 (1984): 131-32. <em>Ncbi.gov.</em> Web. 10 Oct. 2012.</p></span></p>

Request a Quote